Dyne Therapeutics (DYN) stock gains premarket momentum as BMO Capital Markets issus a new Outperform rating on the company. Read more here.

BMO Capital analyst Kostas Biliouris initiated coverage of Dyne Therapeutics (DYN) with an Outperform rating and $50 price target The firm ...

BMO Capital analyst Keith Bachman initiated coverage of SailPoint (SAIL) with an Outperform rating and $26 price target The firm believes ...

Tariffs present an inflationary risk, but bank economists see mostly smooth sailing, with steady growth, modest unemployment ...

The Barrett Financial Group lease deal highlighted some fourth-quarter activity in the Chandler submarket. The Chandler ...

The purchase of the holding company of CrossFirst Bank, headquartered in Leawood, Kansas, gives Busey a foothold in multiple ...

Comical scenes at a tourist hotspot in Chongqing, China, as a woman was filmed 'eating' an entire train on 8. The viewing platform at Binjiang Park has become a thriving attraction for tourists and ...

BMO beat profit on capital markets, wealth management strength Alex Ovechkin is on track to break Wayne Gretzky's NHL career goals record ‘It’s not taxed at all’: Warren Buffett shares the ...

On Monday, BMO Capital Markets upgraded Century Aluminum (NASDAQ:CENX) shares from Market Perform to Outperform, setting a price target at $22.00. The upgrade comes as the analyst, Katja Jancic, sees ...

On Monday, BMO Capital Markets adjusted its stance on Block Inc. (NYSE: SQ), formerly known as Square, upgrading the company's stock rating from Market Perform to Outperform. The upgrade comes ...

Sprouts Farmers Market (NASDAQ:SFM – Free Report) had its price target upped by BMO Capital Markets from $140.00 to $180.00 in a research note released on Friday,Benzinga reports.

BMO Capital Markets strategists Ian Lyngen and Vail Hartman said. For now, the takeaway is "is similar to the changing sentiment on the trade front," they said in a note. "Said differently ...